Grants per year
- 175 - 200 out of 1,272 results
Search results
-
Active
University of Chicago Medicine - Bridging Specialties Quality Improvement (QI) Demonstration Project
Selvan, K. C. (PD/PI)
7/1/24 → 5/31/25
Project: Research project
-
Frameworks: Born Physical, Studied Digitally (BP/SD) - An open platform for making physical archives findable, accessible, interoperable, and (re)usable
Amaral, L. A. N. (PD/PI), Stoeger, T. (Co-PD/PI) & van der Lee, S. (Co-PD/PI)
7/1/24 → 6/30/29
Project: Research project
-
Prot #COVALENT-112: Phase 2 Randomized, Double-blind Trial of BMF-219 Compared to Placebo in Participants with Type 1 Diabetes Mellitus
Aleppo, G. (PD/PI) & Kravarusic, J. (Co-Investigator)
Fortrea, Inc., Biomea Fusion Inc.
6/25/24 → 6/25/27
Project: Research project
-
Suppression of progesterone receptor signaling by heavy metals promotes tamoxifen resistance and metastasis or ER+ breast cancer
Bonini, M. (PD/PI), Khan, S. A. (Co-Investigator) & Kocherginsky, M. (Co-Investigator)
National Institute of Environmental Health Sciences
6/24/24 → 3/31/29
Project: Research project
-
Kim RRF Med and Grad Student Preceptorship FY2024
Cuda, C. M. (PD/PI)
Rheumatology Research Foundation
6/24/24 → 6/23/25
Project: Research project
-
Viral and host determinants of donor-specific anti-HIV/SIV immunity mediated by APOBEC3-enzyme
Hultquist, J. F. (PD/PI)
Texas Biomedical Research Institute, National Institute of Allergy and Infectious Diseases
6/21/24 → 4/30/29
Project: Research project
-
Prot #MT-8421-001: A Phase 1 Open-label, Multicenter, Dose-ranging Study to Investigate Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of MT-8421 as Monotherapy and in Combination with Nivolumab in Patients wit
Chandra, S. (PD/PI)
6/21/24 → 6/21/27
Project: Research project
-
Prot #219606: A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
Benson III, A. B. (PD/PI)
PPD Investigator Services, LLC, GlaxoSmithKline LLC
6/18/24 → 6/18/27
Project: Research project
-
Prot #CPR-05644: STRIVE: The SpiraTion® Valve System (SVS) Post-Market RegIstry Study for SeVere Emphysema
Wahidi, M. M. (PD/PI)
6/10/24 → 6/10/27
Project: Research project
-
Prot #RIN-PF-305: A Randomized, Double-Blind, Placebo-Controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)
Bemiss, B. (PD/PI)
PPD Investigator Services, LLC, United Therapeutics Corporation
6/10/24 → 6/10/27
Project: Research project
-
CANCAN - Spatially resolved metabolic measurements in cells and organs during cancer cachexia
Davidson, S. (PD/PI)
6/1/24 → 5/31/25
Project: Research project
-
Delineating the epigenetic landscape and pro-inflammatory gene expression program associated with familial platelet disorder
Godley, L. A. (PD/PI)
Mark Foundation for Cancer Research (US) Ltd
6/1/24 → 5/30/25
Project: Research project
-
Innate immune triggers of alloantibody induction
Eisenbarth, S. C. (PD/PI) & Williams, A. J. (PD/PI)
National Heart, Lung, and Blood Institute
6/1/24 → 5/31/28
Project: Research project
-
Decoding Mitochondrial NAD Metabolism using Spatial Metabolomics
Chandel, N. (PD/PI), Davidson, S. (Co-Investigator) & Surmeier Jr, D. J. (Co-Investigator)
6/1/24 → 5/31/27
Project: Research project
-
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases
Demonbreun, A. R. (PD/PI) & McNally, E. M. (PD/PI)
National Institute of Neurological Disorders and Stroke
6/1/24 → 5/31/26
Project: Research project
-
CANcer Cachexia Action Network (CANCAN)
Davidson, S. (PD/PI)
6/1/24 → 5/31/27
Project: Research project
-
Bacterial Whispers: Small-Talk Shapes Mammalian Immunity
Davidson, S. (PD/PI) & Davidson, S. (PD/PI)
American Association for Cancer Research
6/1/24 → 5/31/26
Project: Research project
-
RESPONDER-HF, REDUCE-LAP II Retrospective Analysis
Shah, S. J. (PD/PI)
5/30/24 → 5/30/27
Project: Research project
-
Prot #M23-647: First-in-Human Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of the BTK Degrader, ABBV-101, in Participants with B-cell Malignancies
Ma, S. (PD/PI)
5/28/24 → 5/28/27
Project: Research project
-
Prot #CRG‐022‐101: An Open‐label, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of CRG‐022, a CD22‐Directed Autologous Chimeric Antigen Receptor (CAR) T‐cell Therapy in Patients With Relapsed/Refractory Large B‐Cell Lymphoma After CD19‐Dire
Karmali, R. (PD/PI)
Novella Clinical, LLC, CARGO Therapeutics, Inc.
5/24/24 → 5/24/27
Project: Research project
-
Impact of Computer Aided Detection on Trainee Polyp Miss Rate Using A Tandem Colonoscopy Design
Keswani, R. N. (PD/PI)
5/23/24 → 11/23/26
Project: Research project
-
Prot #XL092-305: A Phase 2/3, Randomized, Double-blind, Controlled Study of Zanzalintinib (XL092) in Combination with Pembrolizumab vs Pembrolizumab in the First-line Treatment of Subjects with PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous
Lorch, J.H.-M. (PD/PI)
Quintiles, Inc., Exelixis Inc.
5/22/24 → 5/22/27
Project: Research project
-
Prot #TAK-676-1002: An Open-label, Dose Escalation, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastat
Lorch, J.H.-M. (PD/PI)
Pharmaceutical Research Associates, Inc., Takeda Development Center Americas, Inc.
5/21/24 → 5/21/27
Project: Research project